Review



igf2 anti igf1  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sino Biological igf2 anti igf1
    Igf2 Anti Igf1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igf2+anti+igf1/pm33467925-46-1-6?v=Sino+Biological
    Average 90 stars, based on 3 article reviews
    igf2 anti igf1 - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    the antigoat (igf1) and the anti-rabbit (pax3, myf5, igf2, myostatin) horseradish peroxidase (hrp) detection module  (Protein Simple Inc)
    90
    Protein Simple Inc the antigoat (igf1) and the anti-rabbit (pax3, myf5, igf2, myostatin) horseradish peroxidase (hrp) detection module
    The Antigoat (Igf1) And The Anti Rabbit (Pax3, Myf5, Igf2, Myostatin) Horseradish Peroxidase (Hrp) Detection Module, supplied by Protein Simple Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igf2+anti+igf1/pm38733450-77-5-15?v=Protein+Simple+Inc
    Average 90 stars, based on 1 article reviews
    the antigoat (igf1) and the anti-rabbit (pax3, myf5, igf2, myostatin) horseradish peroxidase (hrp) detection module - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    monoclonal human anti igf1 igf2 therapeutic antibody  (Creative Biolabs)
    86
    Creative Biolabs monoclonal human anti igf1 igf2 therapeutic antibody
    Monoclonal Human Anti Igf1 Igf2 Therapeutic Antibody, supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igf2+anti+igf1/pmc08916021-539-0-7?v=Creative+Biolabs
    Average 86 stars, based on 1 article reviews
    monoclonal human anti igf1 igf2 therapeutic antibody - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    igf2 anti igf1  (Sino Biological)
    90
    Sino Biological igf2 anti igf1
    Igf2 Anti Igf1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igf2+anti+igf1/pm33467925-46-1-6?v=Sino+Biological
    Average 90 stars, based on 1 article reviews
    igf2 anti igf1 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    fully human mab anti- igf1 and –igf2  (MedImmune llc)
    90
    MedImmune llc fully human mab anti- igf1 and –igf2
    Intracellular pathway associated with IGF1R activation. IGF1R activation by INS, IGF1 and <t>IGF2,</t> leads to autophosphorylation on tyrosines 1131, 1135 and 1136 in the kinase domain, followed by recruitment of specific docking intermediates, such as members of the IRS family (IRS-1, IRS-2, IRS-3, IRS-4). This molecule link the IGF1R to diverse signalling pathways, allowing the induction of growth, transformation, differentiation and protection against apoptosis, primarily through the activation of the PI3K/Akt/mTOR and the Ras GTPase/Raf-1 (Raf)/Mek (MAPK)/Erk (ERK1/2) signalling pathways.
    Fully Human Mab Anti Igf1 And –Igf2, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igf2+anti+igf1/pmc04164328-0-11-2?v=MedImmune+llc
    Average 90 stars, based on 1 article reviews
    fully human mab anti- igf1 and –igf2 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Intracellular pathway associated with IGF1R activation. IGF1R activation by INS, IGF1 and IGF2, leads to autophosphorylation on tyrosines 1131, 1135 and 1136 in the kinase domain, followed by recruitment of specific docking intermediates, such as members of the IRS family (IRS-1, IRS-2, IRS-3, IRS-4). This molecule link the IGF1R to diverse signalling pathways, allowing the induction of growth, transformation, differentiation and protection against apoptosis, primarily through the activation of the PI3K/Akt/mTOR and the Ras GTPase/Raf-1 (Raf)/Mek (MAPK)/Erk (ERK1/2) signalling pathways.

    Journal: Infectious Agents and Cancer

    Article Title: The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets

    doi: 10.1186/1750-9378-9-27

    Figure Lengend Snippet: Intracellular pathway associated with IGF1R activation. IGF1R activation by INS, IGF1 and IGF2, leads to autophosphorylation on tyrosines 1131, 1135 and 1136 in the kinase domain, followed by recruitment of specific docking intermediates, such as members of the IRS family (IRS-1, IRS-2, IRS-3, IRS-4). This molecule link the IGF1R to diverse signalling pathways, allowing the induction of growth, transformation, differentiation and protection against apoptosis, primarily through the activation of the PI3K/Akt/mTOR and the Ras GTPase/Raf-1 (Raf)/Mek (MAPK)/Erk (ERK1/2) signalling pathways.

    Article Snippet: MEDI-573 , MedImmune LLC , Fully Human mAb anti- IGF1 and –IGF2 , 1b/2 , Completed , In combination with sorafenib , Unresectable or metastatic HCC.

    Techniques: Activation Assay, Transformation Assay

    Currently available agents against the IGF pathway evaluated in clinical trials for the treatment of HCC

    Journal: Infectious Agents and Cancer

    Article Title: The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets

    doi: 10.1186/1750-9378-9-27

    Figure Lengend Snippet: Currently available agents against the IGF pathway evaluated in clinical trials for the treatment of HCC

    Article Snippet: MEDI-573 , MedImmune LLC , Fully Human mAb anti- IGF1 and –IGF2 , 1b/2 , Completed , In combination with sorafenib , Unresectable or metastatic HCC.

    Techniques: Clinical Proteomics, Recombinant